Piermont Capital Management’s Chemed CHE Stock Holding History

Piermont Capital Management’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,100	Closed	-$691K	–	246
2016 Q1	$691K	Buy	5,100 +190	+4%	+$25.7K	0.22%	115
2015 Q4	$736K	Sell	4,910 -330	-6%	-$48.8K	0.23%	110
2015 Q3	$699K	Hold	5,240	–	–	0.23%	108
2015 Q2	$687K	Hold	5,240	–	–	0.21%	115
2015 Q1	$626K	Buy	+5,240	New	+$582K	0.19%	130

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Piermont Capital Management's CHE Position: Q2 2016 in Review

Piermont Capital Management sold out of Chemed (CHE) in Q2 2016, closing a stake of 5,100 shares — an estimated $691K sold.

Piermont Capital Management first reported a position in CHE in Q1 2015 and held it in 5 quarters. The position peaked at $736K in Q4 2015. 244 funds tracked by Wall St. Rank hold CHE as of Q2 2016.

Piermont Capital Management reported no remaining Chemed position as of Q2 2016 after selling out during the quarter.
Piermont Capital Management sold 5,100 Chemed shares in Q2 2016, an estimated $691K.
Piermont Capital Management first reported a position in Chemed in Q1 2015 and held it in 5 quarters.
Piermont Capital Management's Chemed position peaked at $736K in Q4 2015.
244 funds tracked by Wall St. Rank held Chemed as of Q2 2016.

Based on Piermont Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.